Supreme Court Takes On Hikma's 'Skinny Label' Patent Case
By Ryan Davis · January 16, 2026, 2:51 PM EST
The U.S. Supreme Court agreed Friday to hear Hikma Pharmaceuticals Inc.'s appeal of a decision reviving a patent case over its "skinny label" on a generic heart drug, after the Trump...
To view the full article, register now.